ACA
LBPS

Apis Capital Advisors’s 4D Pharma PLC LBPS Stock Holding History

Apis Capital Advisors’s Portfolio LBPS Stock Details LBPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-37,657
Closed -$445K – 51
2021
Q1 		$445K Buy
+37,657
New +$470K 0.4% 40

Other funds holding LBPS

RL
Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Apis Capital Advisors's LBPS Position: Q2 2021 in Review

Apis Capital Advisors sold out of 4D Pharma PLC (LBPS) in Q2 2021, closing a stake of 37,657 shares — an estimated $445K sold.

Apis Capital Advisors first reported a position in LBPS in Q1 2021 and held it in 1 quarter. The position peaked at $445K in Q1 2021. 4 funds tracked by Wall St. Rank hold LBPS as of Q2 2021.

  • Apis Capital Advisors reported no remaining 4D Pharma PLC position as of Q2 2021 after selling out during the quarter.
  • Apis Capital Advisors sold 37,657 4D Pharma PLC shares in Q2 2021, an estimated $445K.
  • Apis Capital Advisors first reported a position in 4D Pharma PLC in Q1 2021 and held it in 1 quarter.
  • Apis Capital Advisors's 4D Pharma PLC position peaked at $445K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held 4D Pharma PLC as of Q2 2021.

Based on Apis Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.